Rothman Institute Orthopaedics
rothmanortho.comLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
116
Active
4
Phase 3
16
Total enrollment
20,306
Pipeline matrix
Showing 5 of 5 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Dexamethasone | — | — | — | — | 4 | ||
| Bupivacaine Hcl 0.5% Inj | — | — | — | — | — | 1 | |
| sterile saline solution | — | — | — | — | — | 1 | |
| Surgiphor | — | — | — | — | — | 1 | |
| Liposomal bupivacaine | — | — | — | 3 |
Next readouts
- 2025-08-30
- 2025-09-30
Top conditions
- Pain, Postoperative10
- Postoperative Pain5
- Osteoarthritis5
- Rotator Cuff Tears4
- Total Joint Arthroplasty4
- Osteo Arthritis Knee3
- Total Hip Arthroplasty3
- Staphylococcus Aureus3
Frequently asked questions about Rothman Institute Orthopaedics
- How many clinical trials does Rothman Institute Orthopaedics have on ClinicalTrials.gov?
- Rothman Institute Orthopaedics is listed as the lead sponsor on 116 clinical trials in ClinicalTrials.gov, 4 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Rothman Institute Orthopaedics's trials are in Phase 3?
- 16 of Rothman Institute Orthopaedics's trials are in Phase 3, spread across 5 active drug programs.
- What therapeutic areas does Rothman Institute Orthopaedics focus on?
- Rothman Institute Orthopaedics's most-studied conditions on ClinicalTrials.gov are Pain, Postoperative, Postoperative Pain, Osteoarthritis, Rotator Cuff Tears, Total Joint Arthroplasty.
- When are Rothman Institute Orthopaedics's next clinical trial readouts?
- Rothman Institute Orthopaedics has 2 upcoming primary-completion readouts tracked here; the soonest is “Exparel v Dexamethasone in RCR”, expected around 2025-08-30.